ASX Filings

Becoming a substantial holder

January 27, 2022

Ceasing to be a substantial holder

January 25, 2022

Opthea Receives A$6.6 m R&D Tax Incentive

January 24, 2022

Additional Formats

PDF Version

Becoming a substantial holder

January 24, 2022

Ceasing to be a substantial holder

January 17, 2022

Change in substantial holding

January 17, 2022

Becoming a substantial holder

January 14, 2022

Opthea To Present at H.C. Wainwright BIOCONNECT Virtual Conference

January 4, 2022

Additional Formats

PDF Version

Opthea Appoints Chief Commercial Officer to Lead Commercialization of OPT-302 for Wet AMD

January 3, 2022

Additional Formats

PDF Version

Ceasing to be a substantial holder

December 23, 2021